The human coronavirus-SARS (SARS-CoV) is most likely the sole agent of Severe Acute Respiratory Syndrome (SARS). Given the significant morbidity and mortality caused by SARS-CoV infections, it is important that we understand the pathogenesis of this infection, in order to design effective vaccines and antiviral therapy. Coronaviruses, particularly murine coronaviruses, have been extensively studied in the past 20 years. In this PPG, several investigators with extensive experience in the pathogenesis and molecular biology of, and host immune response to, coronaviruses and other infections will investigate the pathogenesis of SARS-CoV. The central objective will be to characterize the interaction of SARS-CoV with the immune system and with target cells in the respiratory tract. This objective will be investigated in the following projects. Project 1-To develop a murine model of SARS-CoV using recombinant SARS-CoV and HCoV-OC43, a coronavirus that causes the common cold. To examine SARS-CoV proteins for their ability to modulate the immune response in the context of coronavirus infections. Project 2-To determine if SARS-CoV proteins modulate the adaptive immune response, dendritic cell function or lung pathology, using well characterized infectious models of respiratory viral infections. To begin to identify CD8 T cell epitopes recognized in humans infected with SARSCoV using HLA-A-2 transgenic mice. Project 3-To study interactions of SARS-CoV with airway epithelia using well differentiated cultures of human airway epithelia. To investigate the role of siRNA in modifying the airway cell infection caused by SARS-CoV. Project 4-To study interactions of the surface glycoprotein, responsible for binding to susceptible cells, with its host cell receptor, with particular reference to human airway cells. To identify domains of the SARS-CoV S protein that are critical in pathogenesis. These projects are all interrelated, will provide new information about the SARS-CoV pathogenesis and will take advantage of the unique skills and expertise of the project directors and co-directors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI060699-02
Application #
6927274
Study Section
Special Emphasis Panel (ZAI1-HSD-M (M1))
Program Officer
Cassels, Frederick J
Project Start
2004-08-01
Project End
2009-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$1,438,128
Indirect Cost
Name
University of Iowa
Department
Pediatrics
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Canton, Javier; Fehr, Anthony R; Fernandez-Delgado, Raúl et al. (2018) MERS-CoV 4b protein interferes with the NF-?B-dependent innate immune response during infection. PLoS Pathog 14:e1006838
Fehr, Anthony R; Jankevicius, Gytis; Ahel, Ivan et al. (2018) Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis. Trends Microbiol 26:598-610
Alshukairi, Abeer N; Zheng, Jian; Zhao, Jingxian et al. (2018) High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia. MBio 9:
Sodhi, Chhinder P; Wohlford-Lenane, Christine; Yamaguchi, Yukihiro et al. (2018) Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Physiol Lung Cell Mol Physiol 314:L17-L31
Castaño-Rodriguez, Carlos; Honrubia, Jose M; Gutiérrez-Álvarez, Javier et al. (2018) Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis. MBio 9:
Zheng, Jian; Perlman, Stanley (2018) Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host. Curr Opin Virol 28:43-52
Chu, Daniel K W; Hui, Kenrie P Y; Perera, Ranawaka A P M et al. (2018) MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci U S A 115:3144-3149
Galasiti Kankanamalage, Anushka C; Kim, Yunjeong; Damalanka, Vishnu C et al. (2018) Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. Eur J Med Chem 150:334-346
Grunewald, Matthew E; Fehr, Anthony R; Athmer, Jeremiah et al. (2018) The coronavirus nucleocapsid protein is ADP-ribosylated. Virology 517:62-68
Tai, Wanbo; Wang, Yufei; Fett, Craig A et al. (2017) Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. J Virol 91:

Showing the most recent 10 out of 111 publications